Trial intelligence / Profile preview

Weekly maintenance paclitaxel vs control after first-line chemotherapy in metastatic breast cancer

2004-004031-59Phase 3Terminated

Sponsor
AOU Policlinico di Modena
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of paclitaxel in breast cancer (2 arms), sponsored by AOU Policlinico di Modena. Started Jul 2005; status: terminated.

02

Drugs

paclitaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2004-004031-59.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004031-59.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call